VERACYTE, INC. Net Income (Loss) Available to Common Stockholders, Basic
VERACYTE, INC. (VCYT) reported Net Income (Loss) Available to Common Stockholders, Basic of $25.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-07-31
- VERACYTE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was $25.49M.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was $28.71M, a 307.36% increase year-over-year.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was $41.15M, a 704.79% increase year-over-year.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was $19.14M, a 26.28% increase year-over-year.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was $66.35M, a 174.89% increase from fiscal 2024.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was $24.14M.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$74.40M.
- VERACYTE, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$36.56M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.49M 10-Q · filed 2026-07-31 | $54.20M 10-Q · filed 2026-07-31 | $95.35M derived: sum of 3 quarters · filed 2026-07-31 | $114.48M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $28.71M 10-Q · filed 2026-05-06 | $69.86M derived: sum of 2 quarters · filed 2026-05-06 | $88.99M derived: sum of 3 quarters · filed 2026-05-06 | $88.01M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $41.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $60.29M derived: sum of 2 quarters · filed 2026-02-26 | $59.31M derived: sum of 3 quarters · filed 2026-07-31 | $66.35M 10-K · filed 2026-02-26 |
| 2025-09-30 | $19.14M 10-Q · filed 2025-11-05 | $18.16M derived: sum of 2 quarters · filed 2026-07-31 | $25.20M 10-Q · filed 2025-11-05 | $30.32M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | -$980.00K 10-Q · filed 2026-07-31 | $6.07M 10-Q · filed 2026-07-31 | $11.18M derived: sum of 3 quarters · filed 2026-07-31 | $26.34M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $7.05M 10-Q · filed 2026-05-06 | $12.16M derived: sum of 2 quarters · filed 2026-05-06 | $27.32M derived: sum of 3 quarters · filed 2026-05-06 | $33.05M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.27M derived: sum of 2 quarters · filed 2026-02-26 | $26.00M derived: sum of 3 quarters · filed 2026-02-26 | $24.14M 10-K · filed 2026-02-26 |
| 2024-09-30 | $15.15M 10-Q · filed 2025-11-05 | $20.89M derived: sum of 2 quarters · filed 2025-11-05 | $19.02M 10-Q · filed 2025-11-05 | -$9.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $5.73M 10-Q · filed 2025-08-07 | $3.87M 10-Q · filed 2025-08-07 | -$24.42M derived: sum of 3 quarters · filed 2026-02-26 | -$54.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.86M 10-Q · filed 2025-05-08 | -$30.16M derived: sum of 2 quarters · filed 2026-02-26 | -$59.77M derived: sum of 3 quarters · filed 2026-02-26 | -$68.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$28.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$57.91M derived: sum of 2 quarters · filed 2026-02-26 | -$66.31M derived: sum of 3 quarters · filed 2026-02-26 | -$74.40M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$29.62M 10-Q · filed 2024-11-07 | -$38.02M derived: sum of 2 quarters · filed 2024-11-07 | -$46.11M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$8.40M 10-Q · filed 2024-08-07 | -$16.49M 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | -$36.56M 10-K · filed 2025-02-28 | |||
| 2020-03-31 | -$11.72M 10-Q · filed 2020-05-06 | -$19.17M derived: sum of 2 quarters · filed 2020-05-06 | -$19.90M derived: sum of 3 quarters · filed 2020-05-06 | -$22.40M derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | -$7.46M 10-K · filed 2020-02-25 | -$8.19M derived: sum of 2 quarters · filed 2020-02-25 | -$10.68M derived: sum of 3 quarters · filed 2020-02-25 | -$12.60M 10-K · filed 2020-02-25 |
| 2019-09-30 | -$730.00K 10-K · filed 2020-02-25 | -$3.22M derived: sum of 2 quarters · filed 2020-02-25 | -$5.14M 10-Q · filed 2019-10-22 | -$8.25M derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-06-30 | -$2.49M 10-K · filed 2020-02-25 | -$4.41M 10-Q · filed 2019-07-30 | -$7.52M derived: sum of 3 quarters · filed 2020-05-06 | -$11.98M derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-03-31 | -$1.92M 10-Q · filed 2020-05-06 | -$5.02M derived: sum of 2 quarters · filed 2020-05-06 | -$9.49M derived: sum of 3 quarters · filed 2020-05-06 | -$15.74M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$3.10M 10-K · filed 2020-02-25 | -$7.57M derived: sum of 2 quarters · filed 2020-02-25 | -$13.82M derived: sum of 3 quarters · filed 2020-02-25 | -$23.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$4.47M 10-K · filed 2020-02-25 | -$10.72M derived: sum of 2 quarters · filed 2020-02-25 | -$19.89M 10-Q · filed 2019-10-22 | -$28.33M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$6.25M 10-K · filed 2020-02-25 | -$15.43M 10-Q · filed 2019-07-30 | -$23.86M derived: sum of 3 quarters · filed 2020-02-25 | -$30.91M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$9.18M 10-K · filed 2020-02-25 | -$17.62M derived: sum of 2 quarters · filed 2020-02-25 | -$24.66M derived: sum of 3 quarters · filed 2020-02-25 | -$31.96M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$8.44M 10-K · filed 2019-02-25 | -$15.49M derived: sum of 2 quarters · filed 2019-02-25 | -$22.79M derived: sum of 3 quarters · filed 2019-02-25 | -$31.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$7.05M 10-K · filed 2019-02-25 | -$14.35M derived: sum of 2 quarters · filed 2019-02-25 | -$22.56M 10-Q · filed 2018-10-29 | -$26.97M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | -$7.30M 10-K · filed 2019-02-25 | -$15.52M 10-Q · filed 2018-07-23 | -$19.92M derived: sum of 3 quarters · filed 2019-02-25 | -$25.55M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$8.22M 10-K · filed 2019-02-25 | -$12.62M derived: sum of 2 quarters · filed 2019-02-25 | -$18.26M derived: sum of 3 quarters · filed 2019-02-25 | -$29.50M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | -$4.40M 10-K · filed 2018-02-27 | -$10.04M derived: sum of 2 quarters · filed 2018-02-27 | -$21.28M derived: sum of 3 quarters · filed 2018-02-27 | -$31.36M 10-K · filed 2019-02-25 |
| 2016-09-30 | -$5.64M 10-K · filed 2018-02-27 | -$16.88M derived: sum of 2 quarters · filed 2018-02-27 | -$26.95M 10-Q · filed 2017-11-07 | -$34.97M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$11.24M 10-K · filed 2018-02-27 | -$21.32M 10-Q · filed 2017-07-31 | -$29.33M derived: sum of 3 quarters · filed 2018-02-27 | -$38.28M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$10.07M 10-K · filed 2018-02-27 | -$18.09M derived: sum of 2 quarters · filed 2018-02-27 | -$27.03M derived: sum of 3 quarters · filed 2018-02-27 | -$36.17M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$8.01M 10-K · filed 2017-03-01 | -$16.96M derived: sum of 2 quarters · filed 2017-03-01 | -$26.09M derived: sum of 3 quarters · filed 2017-03-01 | -$33.70M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$8.95M 10-K · filed 2017-03-01 | -$18.08M derived: sum of 2 quarters · filed 2017-03-01 | -$25.69M 10-Q · filed 2016-11-03 | -$33.83M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$9.14M 10-K · filed 2017-03-01 | -$16.75M 10-Q · filed 2016-08-03 | -$24.89M derived: sum of 3 quarters · filed 2017-03-01 | -$32.79M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$7.61M 10-K · filed 2017-03-01 | -$15.75M derived: sum of 2 quarters · filed 2017-03-01 | -$23.65M derived: sum of 3 quarters · filed 2017-03-01 | -$30.31M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$8.14M 10-K · filed 2016-03-14 | -$16.04M derived: sum of 2 quarters · filed 2016-03-14 | -$22.70M derived: sum of 3 quarters · filed 2016-03-14 | -$29.37M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$7.90M 10-K · filed 2016-03-14 | -$14.56M derived: sum of 2 quarters · filed 2016-03-14 | -$21.23M 10-Q · filed 2015-11-05 | -$27.12M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | -$6.66M 10-K · filed 2016-03-14 | -$13.33M 10-Q · filed 2015-08-13 | -$19.22M derived: sum of 3 quarters · filed 2016-03-14 | -$25.52M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | -$6.67M 10-K · filed 2016-03-14 | -$12.57M derived: sum of 2 quarters · filed 2016-03-14 | -$18.87M derived: sum of 3 quarters · filed 2016-03-14 | -$25.36M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | -$5.89M 10-K · filed 2015-03-25 | -$12.20M derived: sum of 2 quarters · filed 2015-03-25 | -$18.68M derived: sum of 3 quarters · filed 2015-03-25 | -$25.58M 10-K · filed 2016-03-14 |
| 2013-09-30 | -$6.30M 10-K · filed 2015-03-25 | -$12.79M derived: sum of 2 quarters · filed 2015-03-25 | -$19.69M 10-Q · filed 2014-11-13 | -$24.52M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-06-30 | -$6.49M 10-K · filed 2015-03-25 | -$13.38M 10-Q · filed 2014-08-14 | -$18.22M derived: sum of 3 quarters · filed 2015-03-25 | -$23.16M derived: sum of 4 quarters · filed 2015-03-25 |
| 2013-03-31 | -$6.89M 10-K · filed 2015-03-25 | -$11.73M derived: sum of 2 quarters · filed 2015-03-25 | -$16.67M derived: sum of 3 quarters · filed 2015-03-25 | |
| 2012-12-31 | -$4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | -$9.78M derived: sum of 2 quarters · filed 2015-03-25 | -$18.65M 10-K · filed 2015-03-25 | |
| 2012-09-30 | -$4.94M 10-Q · filed 2013-11-25 | -$13.81M 10-Q · filed 2013-11-25 | ||
| 2011-12-31 | -$14.45M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |